Mercedes
Iñarrairaegui Bastarrica
Consultora Médica
University of Tübingen
Tubinga, AlemaniaUniversity of Tübingen-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566